---
figid: PMC8709313__pharmaceutics-13-02201-g001
figtitle: TKI Era in Chronic Leukemias
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8709313
filename: pharmaceutics-13-02201-g001.jpg
figlink: /pmc/articles/PMC8709313/figure/pharmaceutics-13-02201-f001/
number: F1
caption: BCR-ABL1 signaling pathway.
papertitle: The TKI Era in Chronic Leukemias.
reftext: Danilo De Novellis, et al. Pharmaceutics. 2021 Dec;13(12):2201.
year: '2021'
doi: 10.3390/pharmaceutics13122201
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: chronic myeloid leukemia (CML) | chronic lymphocytic leukemia (CLL) | BCR-ABL1-inhibitors
  | BTK-inhibitors | PI3K-inhibitors | targeted therapy | treatment discontinuation
automl_pathway: 0.9524764
figid_alias: PMC8709313__F1
figtype: Figure
redirect_from: /figures/PMC8709313__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8709313__pharmaceutics-13-02201-g001.html
  '@type': Dataset
  description: BCR-ABL1 signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - BCR
  - RN7SL263P
  - ABL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - QRSL1
  - GATA1
  - GATA2
  - GATA3
  - GATA4
  - GATA5
  - GATA6
  - JAK2
  - NFKB1
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - MDM2
  - TP53
  - TP63
  - TP73
  - MYC
  - KRAS
  - HRAS
  - NRAS
  - JUN
  - JUNB
  - JUND
  - RAF1
  - RNASE3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
---
